Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.

Florent ArtruLorenzo AlberioDarius MoradpourGrégoire Stalder

Published in: BMJ case reports (2020)

We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.

Keyphrases

coronavirus disease
high dose
sars cov
case report
heart failure
liver failure
respiratory syndrome coronavirus
low dose
stem cell transplantation
intensive care unit
drug induced
autism spectrum disorder
hepatitis b virus
intellectual disability
respiratory failure